Literature DB >> 24566956

Hypertension: treatment-resistant hypertension - a risk factor for ESRD.

Markus P Schlaich1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24566956     DOI： 10.1038/nrneph.2014.26

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Incidence and prognosis of resistant hypertension in hypertensive patients.

Authors:  Stacie L Daugherty; J David Powers; David J Magid; Heather M Tavel; Frederick A Masoudi; Karen L Margolis; Patrick J O'Connor; Joe V Selby; P Michael Ho
Journal:  Circulation       Date:  2012-02-29       Impact factor: 29.690

2.  Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring.

Authors:  Alejandro de la Sierra; Julián Segura; José R Banegas; Manuel Gorostidi; Juan J de la Cruz; Pedro Armario; Anna Oliveras; Luis M Ruilope
Journal:  Hypertension       Date:  2011-03-28       Impact factor: 10.190

Review 3.  Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.

Authors:  Rikki M Tanner; David A Calhoun; Emmy K Bell; C Barrett Bowling; Orlando M Gutiérrez; Marguerite R Irvin; Daniel T Lackland; Suzanne Oparil; William McClellan; David G Warnock; Paul Muntner
Journal:  Am J Kidney Dis       Date:  2014-01-01       Impact factor: 8.860

4.  Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension.

Authors:  Sante D Pierdomenico; Domenico Lapenna; Anna Bucci; Roberta Di Tommaso; Rocco Di Mascio; Bianca M Manente; Maria P Caldarella; Matteo Neri; Franco Cuccurullo; Andrea Mezzetti
Journal:  Am J Hypertens       Date:  2005-11       Impact factor: 2.689

5.  Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients.

Authors:  Luca De Nicola; Francis B Gabbai; Rajiv Agarwal; Paolo Chiodini; Silvio Borrelli; Vincenzo Bellizzi; Felice Nappi; Giuseppe Conte; Roberto Minutolo
Journal:  J Am Coll Cardiol       Date:  2013-04-23       Impact factor: 24.094

6.  Prevalence of resistant hypertension in the United States, 2003-2008.

Authors:  Stephen D Persell
Journal:  Hypertension       Date:  2011-04-18       Impact factor: 10.190

7.  Blood pressure is a major risk factor for renal death: an analysis of 560 352 participants from the Asia-Pacific region.

Authors:  Conall M O'Seaghdha; Vlado Perkovic; Tai Hing Lam; Stella McGinn; Federica Barzi; Dong Feng Gu; Alan Cass; Il Suh; Paul Muntner; Graham G Giles; Hirotsugu Ueshima; Mark Woodward; Rachel Huxley
Journal:  Hypertension       Date:  2009-07-13       Impact factor: 10.190

8.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 9.  Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.

Authors:  Dagmara Hering; Murray D Esler; Markus P Schlaich
Journal:  EuroIntervention       Date:  2013-05       Impact factor: 6.534

10.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.